4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-041471
Chief Financial Officer sold 3,762 shares at $41.80 ($157,252)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prasad Raju Chief Financial Officer | 2025-03-14 | Option exercise | +10,000 | 16,476 | D | ||
| Prasad Raju Chief Financial Officer | 2025-03-17 | Sale | −3,762 | $41.80 | $157,252 | 12,714 | D |
| Derivatives | |||||||
| Prasad Raju Chief Financial Officer | 2025-03-14 | Option exercise · Restricted Stock Units | −10,000 | 20,000 | D | ||
| Prasad Raju Chief Financial Officer | 2025-03-14 | Grant or award · Stock Option (Right to Buy) | +36,666 | 36,666 | D | ||
| Prasad Raju Chief Financial Officer | 2025-03-14 | Grant or award · Restricted Stock Units | +27,500 | 27,500 | D | ||
| Open-market sales · 3,762 sh · avg $41.80 · $157,252 | |||||||
Loading xslF345X05/ownership.xml…